Most prostate cancer patients respond initially to androgen ablation and antiandrogen therapy. However, virtually all patients will relapse due to acquisition of the androgen-independent tumor cells. The molecular mechanisms characterizing prostate cancer progression from androgen-dependence to androgen-independence are incompletely understood. Androgen-independent activation of androgen receptor (AR) by cross-talk between AR and other signal pathways has been demonstrated to mediate prostate cancer androgen-independent progression in the absence of androgen. We previously demonstrated that overexpression of interleukin-6 (IL-6) is linked to prostate cancer progression accompanied by activation of Signal Transducers and Activators of Transcription 3 (Stat3) signaling. Further investigation in our laboratory demonstrated that Stat3 is constitutively activated in cells derived from both rat and human prostate cancers, and that Stat3 activation is correlated with malignant potential. In human prostate cancer cells, blockade of Stat3 expression suppressed proliferation in vitro and tumorigenicity in vivo. In addition, preliminary results demonstrate that the Stat3 signaling pathway interacts with the androgen receptor signaling pathway. Based on these results, we propose that Stat3 both regulates the expression of Stat3 target genes, and interacts with AR in prostate cancer cells. The experiments proposed in this application are based upon the hypothesis that Stat3 activation alters androgen receptor signaling pathway resulting in the loss of growth control in prostate cancer cells. Through our proposed analysis of the role of Stat3 activation in AR signaling in prostate cancer cells, we seek to provide a possible mechanism for the development of the androgen-independent prostate cancer cells. To accomplish this goal, we will examine the role of Stat3 activation in AR signaling in prostate cancer cells by establishing prostate cancer cell lines expressing constitutively activated Stat3 and examining the effect of Stat3 activation on androgen response in prostate cancer cells. We will then determine the molecular basis of interactions between Stat3 and the AR signaling. Finally, we will examine the association between Stat3 activation and prostate cancer progression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA090271-02
Application #
6514935
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Sathyamoorthy, Neeraja
Project Start
2001-07-20
Project End
2003-03-18
Budget Start
2002-06-11
Budget End
2003-03-18
Support Year
2
Fiscal Year
2002
Total Cost
$200,618
Indirect Cost
Name
University of Pittsburgh
Department
Urology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Tummala, Ramakumar; Lou, Wei; Gao, Allen C et al. (2017) Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells. Mol Cancer Ther 16:2770-2779
Nadiminty, Nagalakshmi; Dutt, Smitha; Tepper, Clifford et al. (2010) Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells. Prostate 70:276-87
Feng, Siting; Tang, Qizhu; Sun, Meng et al. (2009) Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2. Mol Cancer Ther 8:665-71
Lee, Soo Ok; Chun, Jae Yeon; Nadiminty, Nagalakshmi et al. (2009) Interleukin-4 activates androgen receptor through CBP/p300. Prostate 69:126-32
Nadiminty, Nagalakshmi; Chun, Jae Yeon; Lou, Wei et al. (2008) NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation. Prostate 68:1725-33
Lee, Soo Ok; Pinder, Elaine; Chun, Jae Yeon et al. (2008) Interleukin-4 stimulates androgen-independent growth in LNCaP human prostate cancer cells. Prostate 68:85-91
Hu, Yan; Sun, Meng; Nadiminty, Nagalakshmi et al. (2008) Transcriptional regulation of human RANK ligand gene expression by E2F1. Biochem Biophys Res Commun 370:440-4
Nadiminty, Nagalakshmi; Chun, Jae Yeon; Hu, Yan et al. (2007) LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathway. Biochem Biophys Res Commun 359:379-84
Lee, Soo Ok; Dutt, Smitha S; Nadiminty, Nagalakshmi et al. (2007) Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. Prostate 67:1293-300
Lee, Soo Ok; Chun, Jae Yeon; Nadiminty, Nagalakshmi et al. (2007) Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression. Prostate 67:764-73

Showing the most recent 10 out of 24 publications